New option listings for January 15th include Tradr 2X Long CRML Daily ETF (CRMX), Definium Therapeutics, Inc. (DFTX), Tradr 2X Long ONDS Daily ETF (ONDU), Tradr 2X Long PATH Daily ETF (PATX), and Tradr 2X Long USAR Daily ETF (USAX). Option delistings effective January 15th include MindMed (MNMD).
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MNMD:
- Definium Therapeutics: De-Risked Late-Stage Neuropsychiatric Pipeline Positions 2026 as Catalyst-Rich Year Supporting Buy Rating and $32 Target
- Definium Therapeutics Rebrands and Highlights 2026 Pipeline
- Mind Medicine rebrands to Definium Therapeutics
- Psychedelic: Bright Minds reports results from Phase 2 BMB-101 trial
- Needham names Mind Medicine top pick, adds to Conviction List